State intervention in the pharmaceutical industry: social advance or threat to innovation? By Ivan Topalovic Introduction 1/ The Product A/ European level‚ the “EMEA” B/ R.O.W. a) The Followers b) The non-Followers 2/ The Price A/ Worldwide parameters B/ Examples of price fixing per country 3/ The Place 4/ The Promotion Conclusion Appendix I Chronology in therapeutic innovation Appendix II Major pharmaceutical companies mergers / acquisitions
Premium Pharmacology Clinical trial Generic drug
THE BALANCED SCORECARD IN AN INDONESIAN PHARMACEUTICAL COMPANY A CASE STUDY IN PT. DEXA MEDICA 1. INTRODUCTION 1.1. Background of the Study In modern competitive global economy‚ it is more important than ever to understand the process of value creation in the organization. The need to manage with a high level of customer focus‚ a clearer understanding of core business processes‚ the necessity of motivation and commitment of employees‚ the need for change on a continuous basis‚ and effective
Premium Strategic management Balanced scorecard
Running head: ETHICAL ISSUES IN THE PHARMACEUTICAL INDUSTRY Ethical Issues in the Pharmaceutical Industry Abstract No one can deny that the pharmaceutical industry has made significant contributions to human progress. The pharmaceutical industry has been responsible for drugs that have saved millions of lives‚ cured many forms of cancer‚ and ensured that an AIDS diagnosis is no longer an automatic death sentence. Yet despite this there are questions that the public has on whether the industry
Premium Physician Clinical trial Pharmaceutical industry
in their professional life. Corporate collapse of Enron‚ WorldCom‚ and recent banking scandals have shown that unethical accounting practices and ill-judged decisions can have devastating consequences for a firm‚ individuals‚ investors and‚ in the case of audit work‚ the capital markets. This report discusses the ethical challenges of accountants and
Premium Ethics International Financial Reporting Standards
Table of Contents Introduction: 1 Bangladeshi Pharmaceutical Industry: 2 Industry Analysis: 2 Competitive Force 1: Rivalry among Existing Firms 3 Competitive Force 2: Threat of New Entrants 3 Competitive Force 3: Threat of Substitute Products 3 Competitive Force 4: Bargaining Power of Buyers 4 Competitive Force 5: Bargaining Power of Suppliers 4 Competitive Strategy Analysis: 5 Cost Leadership: 5 Product Differentiation: 5 Corporate Strategy Analysis: 6 Conclusion:………………………………………………………………………………………………………7
Premium Generic drug Pharmacology Pharmaceutical industry
1. What kind of multiproduct strategy is Novartis following? Explain. Novartis acquisition in eye care company Alcon Inc. is an example of Related Diversification Multiproduct Strategy due to the fact that Novartis and Alcon both perform their business in health care industry. In addition‚ Novartis prescription drug make up 60% of the total sales indicate that company is operating in moderate to high level of diversification. The acquisition of Alcon Inc. establishes a related link between
Premium Novartis Pharmaceutical industry
A Look at Data Mining in the Pharmaceutical Industry Topics Covered: 1) What is Data Mining and why is it used? 2) How is Data Mining used in the Pharmaceutical Industry? 3) Recent debate in the legality of Data Mining and the Pharmaceutical Industry Pharmaceutical companies are taking advantage of the growing use of technology in the healthcare arena by using data to enhance their marketing efforts and increase the quality of research and development. The process of data mining
Premium Data mining Pharmaceutical industry Pharmacology
INTRODUCTION 1.0 BACKGROUND OF THE REPORT: The name of the topic is “Marketing of Pharmaceuticals product: A study on Beximco Pharmaceuticals Limited.” Medicine is directly related to human life and therefore‚ its manufacturers have immense social responsibility of providing safe and effective medicine‚ demanding uncompromising efforts‚ at all levels of its activities. Beximco pharmaceuticals Ltd the leading health care company in Bangladesh has been making every effort to ensure the effectiveness
Premium Marketing Marketing research Pharmaceutical industry
Research on Pharmaceutical Channel Distribution 2013 Medhad Nasser Chowdhury 082735530 4/30/2013 MKT 450.1 Faculty Members: Shahed Hussain The New Era A journey through the pharmaceutical channel system in Bangladesh Abstract The aim of the study is to analyze the changes that took place in Bangladesh Pharmaceutical Industries Channel system in the past decade. The current scenario of the pharmaceutical Industry in Bangladesh and external effects that might bring in
Premium Marketing Pharmaceutical industry Supply chain
Pharmaceutical Advertising Americans constantly see advertisements on TV‚ in magazines‚ and on websites about prescription drugs encouraging viewers to recommend prescription drugs to their doctors that they may not even need. In 2007‚ the average American watched approximately sixteen hours of pharmaceutical advertisements per year (Mulligan). Even though these commercials may seem funny or just annoying‚ they impact how we think about how prescription drugs are (or should be) marketed
Premium Pharmacology Marketing Advertising